We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
ResoTher Pharma: Improving Cardiovascular Outcomes
Please read our biography published in Life Sciences Review 'Company [...]
ResoTher Pharma receives a €2.5 million grant from the European Innovation Council
ResoTher Pharma, a biotech company focused on developing life-saving [...]
ResoTher Pharma appoints Anders Kronborg as Chief Executive Officer
Resother Pharma A/S (“ResoTher”) today announced the appointment of Anders [...]
Latest News
ResoTher Pharma: Improving Cardiovascular Outcomes
Please read our biography published in Life Sciences Review 'Company [...]
ResoTher Pharma receives a €2.5 million grant from the European Innovation Council
ResoTher Pharma, a biotech company focused on developing life-saving [...]
ResoTher Pharma appoints Anders Kronborg as Chief Executive Officer
Resother Pharma A/S (“ResoTher”) today announced the appointment of Anders [...]
